Search
CUDC-101
go.drugbank.com/drugs/DB12174InvestigationalCUDC-101 has been used in trials studying the treatment of Cancer, Tumors, Liver Cancer, Breast Cancer, and Gastric Cancer, among others.
RTL-1000
go.drugbank.com/drugs/DB17946InvestigationalRTL-1000 is a recombinant T-Cell receptor ligand being investigated for the treatment of multiple sclerosis.
Synonyms: RTL 1000, Recombinant t-cell receptor ligand rtl-1000Pacritinib
go.drugbank.com/drugs/DB11697ApprovedInvestigationalof both primary and secondary MF in patients with platelet counts < 50 x 10<sup>9</sup>/L. … [L40793] Approximately 50% of patients with primary MF have a mutation of the _JAK2_ gene, which is also commonly mutated in patients with polycythemia vera or essential thrombocythemia.
Categories: Cytochrome P-450 CYP1A2 Inducers, Cytochrome P-450 SubstratesAlginic acid
go.drugbank.com/drugs/DB13518ApprovedInvestigationalWithdrawnAvailable in different types of salt, alginic acid has been used in a variety of uses in food, cosmetics and pharmaceu-tical products for over 100 years [A32961]. … Alginate-based raft-forming formulations in the management of heartburn and gastric acid reflux have been used worldwide for over 30 years [A32961].
Mixtures: GASTOPAL DUO 600 MG+70 MG+150 MG/5 ML SÜSPANSİYON, 100 ML, RENNIE DUO 600 MG+ 70 MG+150 MG/5 ML SUSPANSIYON, 100 MLProducts: REFLUFIN 2.5 G SUSPENSIONLevosulpiride
go.drugbank.com/drugs/DB16021InvestigationalProducts: LEVOGASTROL® 25 MG, LEVOSULPIRIDE25 MG TABLETASLesinidase alfa
go.drugbank.com/drugs/DB15267InvestigationalLesinidase alfa is under investigation in clinical trial NCT02324049 (Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in Mucopolysaccharidosis III, Type B (MPS IIIB)).
Synonyms: SBC-103Rivipansel
go.drugbank.com/drugs/DB12778InvestigationalRivipansel has been used in trials studying the other, basic science, and treatment of Pain Crisis, Renal impairment, Anemia, Sickle Cell, Sickle Cell Disease, and Sickle Cell Disorders, among others.
Synonyms: GMI-1070CAN-106
go.drugbank.com/drugs/DB18389InvestigationalCAN-106 a novel, long-acting monoclonal antibody directed against human complement C5.
Synonyms: Immunoglobulin G [27-histidine,57-histidine,253-tyrosine,255- threonine,257-glutamic acid], anti-(human complement C5) (human monoclonal CAN106 hybrid y2-chain CH1-hinge region/y4-chain CH2- CH3 regionAP-101
go.drugbank.com/drugs/DB17947InvestigationalAP-101 is a recombinant human antibody directed against human misfolded superoxide dismutase 1.
GI-101
go.drugbank.com/drugs/DB17243InvestigationalGI-101 is a bi-specific fragment crystallizable region (Fc) fusion protein containing a cluster of differentiation 80 ectodomain as an N-terminal moiety and interleukin-2 variant as a C-terminal moiety